Jalpa A. Doshi, PhD, is Professor of Medicine at the Perelman School of Medicine. She is also Director of Value Based Insurance Design Initiatives at the Center for Health Incentives and Behavioral Economics and Director of the Economic Evaluations Unit of the Center for Evidence-based Practice at Penn. The goal of her research program is to understand how pharmaceuticals can be better accessed and utilized in the health care system to improve health care quality while balancing costs. Her research focuses on three broad areas: 1) impact of prescription benefit design and reimbursement policies on access to prescription drugs, and the quality and cost of health care; 2) prevalence, causes, outcomes, and costs of suboptimal medication use in chronic diseases and the clinical and economic impact of innovative behavioral or policy interventions for improving medication adherence and management; and 3) advancing the methods used in pharmaceutical outcomes and cost-effectiveness research to enhance its usefulness in real world decision-making by patients, providers, payers, and policymakers. In recent years, her research program in all three areas has focused on specialty drugs.
She has co-authored Economic Evaluation in Clinical Trials (Oxford University Press). Her research has been featured in the New York Times and Wall Street Journal and has been recognized by organizations such as the American Geriatrics Society, American Heart Association, AcademyHealth, Drug Information Association, and International Society for Pharmacoeconomics and Outcomes Research. She currently serves as Associate Editor of Health Economics. She holds a PhD in Pharmaceutical Health Services Research from the University of Maryland.
Areas of Expertise | Cost Effectiveness, Drug Costs and Pricing, Medication Adherence, Pharmaceuticals
Selected Publications: